Open AccessCalmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)
Author(s) -
Per Pfeiffer,
Maryam B. Lustberg,
Jacques Näsström,
Stefan Carlsson,
Anders Persson,
Fumiko Nagahama,
Guido Cavaletti,
Bengt Glimelius,
Kei Muro
Publication year - 2022
Publication title -
jnci cancer spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.345
H-Index - 10
ISSN - 2515-5091
DOI - 10.1093/jncics/pkac075
Subject(s) - medicine , oxaliplatin , placebo , folinic acid , colorectal cancer , clinical endpoint , peripheral neuropathy , phases of clinical research , randomized controlled trial , clinical trial , cancer , diabetes mellitus , pathology , alternative medicine , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom